Australia's leading research commercialisation company
We commercialise UQ research to create change and deliver solutions for a better world.
Established in 1984, we are Australia’s leading technology transfer company.
Our innovation portfolio includes Australia’s first blockbuster vaccine Gardasil®, the internationally acclaimed Triple P-Positive Parenting Program, UQ’s superconductor technology, which is used in most of the world’s Magnetic Resonance Imaging (MRI) machines, and, in 2015 our spin-out Spinifex Pharmaceuticals secured Australia’s largest ever biotechnology acquisition.
Our commercialisation impact makes UQ Australia’s leading university for licence income and value of equity held in spin-out companies*.
*National Survey of Research Commercialisation, Department of Industry, Innovation and Science, 2016.
Our Vision
Delivering solutions for a better world.
Our Mission
Commercialising UQ research to create change.
Our Values
Open-minded
Respectful of the views of others and open to change.
Act with integrity
Manage conflict of interest, accountable and professional.
Inclusive
Value our people, consultative and communicate effectively.
Trust
Honest, reliable and empowered.
Commercial excellence
Financially astute with timely and disciplined decision-making.
Available technologies
We have a suite of available technologies and discoveries to give your business an innovative edge.